At the Pacific Brain Health Center in Santa Monica, our experts treat a wide range of neurocognitive conditions that affect the brain such as dementia and Alzheimer’s disease. As these are not curable at this time, clinical trials and research are necessary to develop new and more effective ways of halting and even reversing cognitive decline in these diseases. Find out more in this informative video.
The Pacific Neuroscience Institute is pleased to announce the newest neuro-oncologist at the Pacific Brain Tumor Center, Naveed Wagle, MD. Find out more.
Santosh Kesari, MD, PhD, has been granted membership into the BrainMind ecosystem to help accelerate the discovery of breakthroughs in brain science and translate them from the lab to all people. Read more.
Advances in research and clinical practice suggest that unusual vision changes may be an indicator of Alzheimer’s disease. Find out more.
The John Wayne Cancer Institute Auxiliary (JWCIA) honored neurologist and neuro-oncologist Santosh Kesari, MD, PhD, with “The Duke” Special Service Award, and philanthropist and President of Premier Girls Fastpitch Dan Hay with the Generation of Hope Award, at La Odisea, the 34th Odyssey Ball on May 4, 2019. Read more.
Dr. Elmar Nurmemmedov’s fascination with science has taken him across the world to discover drugs that will help cure cancer. Find out more.
A recently published paper by Pacific Neuroscience Institute researchers suggests a promising new approach for a biopsy-free method to identify primary brain tumor genetics for personalized treatment options.
Clinical trials using stem cells have shown promising early results as cellular therapies in regenerative medicine, as well as in potential anti-cancer applications. Read more about Dr. Achal Singh Achrol’s neurosurgery clinical trials program and this leading-edge technology.
Nanotechnology is a compelling new drug delivery method in oncology where nanoparticles are engineered to target therapeutics to kill cancer. Find out more in Dr. Venkata Yenugonda’s review article in the March 2019 issue International Journal of Nanomedicine.
Dr. Yenugonda is driven by his desire to better mankind by developing safe, effective and affordable drugs for difficult diseases that can be easily accessed by everyone. Utilizes a unique, two-pronged approach, he combines drug discovery tools and nanotechnology tools to circumvent existing clinical problems. Learn more.